On December 23, 2024, Binance announced the launch of the 63rd project on Binance Launchpool - Bio Protocol (BIO), a governance and liquidity protocol for decentralized science (DeSci).
Users can contribute BNB and FDUSD to the BIO reward pool on Launchpool after December 24, 2024, 08:00 (UTC+8) to earn BIO, with the activity lasting a total of 10 days.
New Coins Listed
Binance will list Bio Protocol (BIO) on January 03, 2025, at 18:00 (UTC+8), and open trading markets for BIO/USDT, BIO/BNB, BIO/FDUSD, and BIO/TRY, applying seed label trading rules.
1. Launchpool Details
Token Name: Bio Protocol (BIO)
Total Genesis Token Supply: 3,320,000,000 BIO
Maximum token supply: 3,320,000,000 BIO (can be increased through network governance)
Initial circulating supply at Binance listing: 1,296,529,168 BIO (39.05% of total genesis token supply)
Total Launchpool: 99,600,000 BIO (3% of total genesis token supply)
Token contract and network details: Ethereum, 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
Restriction Terms: KYC required
Personal hourly reward cap
BNB Mining Pool: 35,275 BIO
FDUSD Mining Pool: 6,225 BIO
Reward Pool:
BNB Pool: Total rewards 84,660,000 BIO (85%)
FDUSD Pool: Total rewards 14,940,000 BIO (15%)
Activity Time: UTC+8, December 24, 2024, 08:00 to January 03, 2025, 08:00
2. Introduction to Bio Protocol (BIO)
BIO is a governance and liquidity protocol for decentralized science (DeSci). Its mission is to enable a global community of patients, scientists, and biotechnology professionals to co-fund, build, and own tokenized biotechnology projects and intellectual property (IP), thereby accelerating the development of biotechnology.
The team behind BIO helped create Molecule (a tokenized platform for early biomedical research) and VitaDAO (the largest decentralized community for longevity science). Building on these successes, BIO aims to catalyze on-chain scientific economies through decentralized funding, incentives, and liquidity.
This protocol aims to catalyze the on-chain economy of the scientific community (bioDAO) and create a deep, liquid, and efficient market for scientific IP developed by bioDAO.
Core advantages of BioDAO compared to traditional scientific models:
Capital Efficiency: Concentrating resources to lower innovation costs
Flexible working model: Allowing part-time experts to contribute
Sharing Intellectual Property: Incentivizing contributions through intellectual property
Open Access: Eliminating barriers to scientific funding and decision-making
Diversified portfolio: Bundling multiple biotechnology projects simultaneously to reduce risk
3. Token Economics
BIO Token
BIO is the native governance token of the BIO protocol. Holders can use BIO tokens:
• Supporting specific bioDAOs (project screening and management);
• Voting on the issuance or allocation of future BIO tokens;
• Implementing accelerator programs to promote network development.
BIO tokens provide the following rights to holders:
• Governance rights within the bioDAO network;
• Participating in early funding rounds of bioDAO;
• Economic rewards for contributing health data and participating in clinical trials;
• Priority access to funding for new health products from bioDAO.
BIO tokens are issued by the Bio.xyz Association, a non-profit organization responsible for the legal custody of BIO infrastructure and treasury.
• BIO token contract address: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
• vBIO (locked BIO) token contract address: 0x0d2ADB4Af57cdac02d553e7601456739857D2eF4
Initial Allocation
Total Supply: 3,320,000,000
BIO token status: Non-transferable
Maximum Supply: No upper limit, determined by voting of the BIO governance body.
New BIO can be minted for future protocol or network growth. This requires deploying a new token contract to replace the current BIO tokens.
In terms of token allocation, community (total 56%):
- Community Airdrop (6%): 199,200,000 BIO
- Community Auction (20%): 664,000,000 BIO
- Ecosystem Incentives (25%): 830,000,000 BIO
- Molecule Ecosystem Fund (5%): 166,000,000 BIO
Other allocations are as follows:
- Core Contributors (21.2%): 703,840,000 BIO
- Investors (13.6%): 451,520,000 BIO
- Molecule (5%): 166,000,000 BIO
- Advisors (4.2%): 139,440,000 BIO
$BIO token holders vote to fund specific research IP assets, rewarding BioDAO with minted IP tokens, or funding community and infrastructure plans for DeSci DAOs. By monetizing IP (intellectual property), revenue is generated through IP licensing, IP-NFTs, and data contributions. This revenue is reinvested into BioDAO to fund more and better research projects, driving the value of the $BIO token and achieving value empowerment.